NDC 70594-082-01 - Ampicillin and Sulbactam
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70594-082
- Requested NDC
- 70594-082-01
- Package NDCs from labels
- 70594-082-01, 70594-082-02
- Manufacturer
- Xellia Pharmaceuticals USA LLC | Astral SteriTech Private Limited
- Effective date
- 2024-12-10
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| AMPICILLIN - Xellia Pharmaceuticals USA LLC | Astral SteriTech Private Limited | Xellia Pharmaceuticals USA LLC | Astral SteriTech Private Limited | 2024-12-10 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 70594-082-02 | 2024-12-10 | C162847 | 48780-1 | 1030e365-55da-111a-e063-dadaa90a10e2 | Ampicillin and Sulbactam for Injection, USP (For Intramuscular or Intravenous Use) |
| 70594-082-02 | 2024-07-30 | C162847 | 48780-1 | 1030e365-55da-111a-e063-dadaa90a10e2 | Ampicillin and Sulbactam for Injection, USP (For Intramuscular or Intravenous Use) |
| 70594-082-02 | 2024-01-30 | C162847 | 48780-1 | 1030e365-55da-111a-e063-dadaa90a10e2 | Ampicillin and Sulbactam for Injection, USP (For Intramuscular or Intravenous Use) |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 70594-082-01 | EA - Each | 70594-082 | 76df4316-2b18-48f9-ae75-11382a11ab5f | 1 | 2021-11-09 |
| 70594-082-02 | EA - Each | 70594-082 | 5c61e449-ef00-4453-a689-63922f54c1c8 | 1 | 2021-11-09 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ampicillin and Sulbactam | AMPICILLIN SODIUM AND SULBACTAM SODIUM | Hospira, Inc | dc374fa4-350b-425d-a7db-7099fdc64cf1 | 2026-01-21 | Warnings, Adverse reactions | JFN36L5S8K DKQ4T82YE6 |
| Ampicillin and Sulbactam | AMPICILLIN SODIUM AND SULBACTAM SODIUM | Eugia US LLC | 437a26f4-776b-4f74-99b2-09ad79831b0c | 2025-12-18 | Warnings, Adverse reactions | JFN36L5S8K DKQ4T82YE6 |
| AMPICILLIN | AMPICILLIN | Civica, Inc. | a194f310-a669-4d8f-8c04-ee9ca01939b1 | 2025-12-09 | Warnings, Adverse reactions | JFN36L5S8K |
| Ampicillin Sodium and Sulbactam Sodium | AMPICILLIN SODIUM, SULBACTAM SODIUM | ONESOURCE SPECIALTY PHARMA LIMITED | 573aca0c-111e-4ed3-9bcd-18136cae12cc | 2025-11-28 | Warnings, Adverse reactions | JFN36L5S8K DKQ4T82YE6 |
| ampicillin sodium and sulbactam sodium | AMPICILLIN SODIUM AND SULBACTAM SODIUM | ONESOURCE SPECIALTY PHARMA LIMITED | 44181723-ef09-301b-e063-6394a90a2cad | 2025-11-21 | Warnings, Adverse reactions | JFN36L5S8K DKQ4T82YE6 |
| AMPICILLIN | AMPICILLIN INJECTION | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 302e6df7-37c5-4625-8a61-3e2f302addf2 | 2025-11-07 | Warnings, Adverse reactions | JFN36L5S8K |
| Ampicillin and Sulbactam | AMPICILLIN SODIUM AND SULBACTAM SODIUM | Eugia US LLC | 16fdfdb9-9e26-48d0-8838-570d30c8e897 | 2025-11-04 | Warnings, Adverse reactions | JFN36L5S8K DKQ4T82YE6 |
| Ampicillin Sodium and Sulbactam Sodium | AMPICILLIN SODIUM, SULBACTAM SODIUM | Armas Pharmaceuticals Inc. | 409f8a6d-f54f-415f-994c-ecd2b820caab | 2025-10-31 | Warnings, Adverse reactions | JFN36L5S8K DKQ4T82YE6 |
| Ampicillin | AMPICILLIN | Armas Pharmaceuticals Inc. | 65d94837-ca25-4728-932b-139d3bf4c716 | 2025-10-31 | Boxed warning, Warnings, Adverse reactions | JFN36L5S8K |
| Ampicillin sodium | AMPICILLIN SODIUM | Medical Purchasing Solutions, LLC | 402e7cc7-5ae8-c113-e063-6394a90aa54a | 2025-10-02 | Warnings, Adverse reactions | JFN36L5S8K |
| ampicillin sodium and sulbactam sodium | AMPICILLIN SODIUM AND SULBACTAM SODIUM | Civica, Inc. | e98a36a1-b75b-42b9-ad1a-05004e9587b6 | 2025-09-08 | Warnings, Adverse reactions | JFN36L5S8K DKQ4T82YE6 |
| Ampicillin | AMPICILLIN SODIUM | Eugia US LLC | b7bf2897-8272-4c7d-84e9-6fbba0ea63fa | 2025-08-14 | Warnings, Adverse reactions | JFN36L5S8K |
| Ampicillin | AMPICILLIN SODIUM | Eugia US LLC | 66146d45-0fe4-46b9-b2b1-b67c219088b7 | 2025-08-14 | Warnings, Adverse reactions | JFN36L5S8K |
| Ampicillin and Sulbactam | AMPICILLIN SODIUM AND SULBACTAM SODIUM | Eugia US LLC | adc92303-b62b-41c8-becf-9c3a4e8c3a6b | 2025-08-12 | Warnings, Adverse reactions | JFN36L5S8K DKQ4T82YE6 |
| Ampicillin and Sulbactam | AMPICILLIN SODIUM AND SULBACTAM SODIUM | Eugia US LLC | 2709e9fc-2341-4382-af72-c2e3201bd77a | 2025-08-12 | Warnings, Adverse reactions | JFN36L5S8K DKQ4T82YE6 |
| Ampicillin Sodium and Sulbactam Sodium | AMPICILLIN SODIUM, SULBACTAM SODIUM | Armas Pharmaceuticals Inc. | ac6f8158-9d7e-4b99-af3c-0407c5287b57 | 2025-07-31 | Warnings, Adverse reactions | JFN36L5S8K DKQ4T82YE6 |
| Ampicillin | AMPICILLIN | Armas Pharmaceuticals Inc. | 34e95c91-3767-493c-8716-38e61e7c6674 | 2025-07-31 | Warnings, Adverse reactions | JFN36L5S8K |
| Ampicillin and Sulbactam | AMPICILLIN SODIUM AND SULBACTAM SODIUM | Meitheal Pharmaceuticals Inc. | 9f2ff165-2a21-4155-a4f0-57885a83c7dc | 2025-07-24 | Warnings, Adverse reactions | JFN36L5S8K DKQ4T82YE6 |
| Ampicillin | AMPICILLIN SODIUM | ProPharma Distribution | 364b1db9-e523-7bae-e063-6294a90a651d | 2025-07-18 | Warnings, Adverse reactions | JFN36L5S8K |
| Ampicillin sodium | AMPICILLIN | Civica, Inc. | 2fd0f9fa-5b86-42f7-9a9f-767123638d39 | 2025-06-30 | Warnings, Adverse reactions | JFN36L5S8K |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.